Other Transaction Agreement N000142390991
Award Date
12/16/22
Potential Completion Date
12/15/25
Potential Value
$29M
Funding Federal Agency
Office of the Assistant Secretary for Preparedness and Response
Contracting Federal Agency
Office of Naval Research
Awardee
Deka Research & Development Corp
Ultimate Awardee
Not listed
NAICS Category
Not listed
PSC Category
AC13 - National Defense R&D Services; Department Of Defense - Military; Experimental Development
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed
Major Defense Program
Not listed
Pricing Type
Other
Place of Performance
Manchester, NH 03101, USA
Solicitation Procedures
Broad Agency Announcement
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (HHS ASPR) awarded Deka Research & Development Corp, a for-profit subchapter S corporation based in Manchester, New Hampshire, a $30,100,000 Other Transaction Agreement to develop an "IV Fluid Therapy Modular Manufacturing System." This contract, which does not have a set-aside designation, aims to bolster national preparedness for public health emergencies by ensuring access...
<p>This is a $11,000,000.00 definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Deka Research & Development Corp, a for-profit Subchapter S Corporation. The contract is for advanced research on a distributed intravenous (IV) solution, with a completion date of August 14, 2020. The contract is a firm fixed price arrangement and was not set aside for any particular business type.</p>
This is a $29,266,207.99 firm fixed price contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Advanced Regenerative Manufacturing Institute Inc. (Armi), a non-profit organization. The contract aims to establish the Foundry for American Biotechnology (NEXTFAB) to accelerate research, development, manufacturing, and deployment of revolutionary advances in science to support pandemic preparedness and...
This is a cost-plus-fixed-fee definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Deka Integrated Solutions Corp., a for-profit subchapter S corporation. The $8,904,988.00 contract is for the development of prosthetic arms and related support for DARPA's HAPTIX program and follow-on Revolutionizing Prosthetics studies. The contract has an ultimate completion date of December 31, 2023 and does not have a set-aside designation. Deka Integrated Solutions Corp. is...
The Department of Health and Human Services awarded a $1,566,897.00 definitive contract to Advanced Regenerative Manufacturing Institute Inc. (Armi), a non-profit organization, to establish a Biofab Foundry - a scalable, closed, automated, medical product manufacturing system. This cost-no-fee contract aims to strengthen domestic biomanufacturing infrastructure for public health emergencies. Armi will develop improved anti-viral coatings for masks through a subcontract with Deka Research &...
The Department of Health and Human Services (HHS), through the Office of the Assistant Secretary for Preparedness and Response (ASPR), awarded a $618,200 firm-fixed-price contract to Bugseq Bioinformatics Inc. for the development of scalable sequencing approaches to detect novel pathogens. This contract, which has a completion date of January 31, 2024, was awarded under ASPR-22-00799, a solicitation issued under the Easy Broad Agency Announcement (EZ-BAA) from the Division of Research,...
The U.S. Department of Health and Human Services, through the Office of the Assistant Secretary for Preparedness and Response, awarded a $60,702,067.00 cost-plus-fixed-fee contract to The Charles Stark Draper Laboratory, Inc. (Draper) to advance the development of a medical countermeasure (MCM) evaluation platform. The platform will consist of vascular-immune and small intestine-immune organ-on-chip models, molecular assays, omics-based technologies, and advanced analytical methods for biomarker...
This is a definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the Department of Health and Human Services, to Selux Diagnostics, Inc. as the prime contractor. The $70,578,261.84 contract is for cost plus fixed fee work and does not have a set-aside designation. The contract involves the development and delivery of products and services to support ASPR's mission. Key subcontractors include Beckman Coulter, Inc. for...
This is a $749,000.00 Firm Fixed Price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS), to HDT Bio Corp. The contract supports Research and Development (R&D) on the use of HDT Bio's Lion-ReRNA technology in rapid response vaccine development, specifically for an Accelerated Capabilities Initiative (AOI) focused on "Vaccine on Demand." The...
This is a federal contract award to Regeneron Pharmaceuticals Inc., a for-profit manufacturer of pharmaceuticals and therapeutics. The $692,086,314.00 award was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract is for the development and production of "novel antibodies against influenza virus, emerging, re-emerging, and pre-emerging pathogens" under an Other...